Ellen Ritchie

5PUBLICATIONS
22CO-AUTHORS
Haematological tumoursHaematologyEpidemiological methodsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 17, 2026
Phase 1b study of ABBV-744, a novel, selective BET inhibitor, as monotherapy for patients with myelofibrosis.

John O Mascarenhas, Laura Maria Fogliatto, Steven D Green

|Oct 07, 2022
Patient-reported outcomes of patients with myelofibrosis or essential thrombocythemia enrolled in the MOST study.

Ellen Ritchie, Anas Al-Janadi, Craig Kessler

|Jul 05, 2022
Hematopoietic fitness of JAK2V617F myeloproliferative neoplasms is linked to clinical outcome.

Ghaith Abu-Zeinah, Silvana Di Giandomenico, Daniel Choi

Pageof 1